Association Between Anti‐TIF1‐γ Antibody and Triple‐Negative Breast Carcinoma in Dermatomyositis Patients: A Case Report
Fan Zhang, Hailing Guo, Jia Ma
TL;DR
This case report explores a possible link between anti-TIF1-γ antibodies and triple-negative breast cancer in a patient with dermatomyositis.
Contribution
The paper presents a case suggesting a potential association between anti-TIF1-γ antibodies and triple-negative breast carcinoma in dermatomyositis.
Findings
Anti-TIF1-γ antibody is more common in DM patients with cancer.
A case is presented where anti-TIF1-γ antibody was associated with triple-negative breast carcinoma.
This suggests a possible clinical link between the antibody and this cancer subtype.
Abstract
Dermatomyositis (DM) is always associated with various types of malignancies in previously published reports. Anti‐transcription intermediary factor 1‐γ (anti‐TIF1‐γ) antibody is more prevalent in DM patients with malignancy than in those without malignancy. In this paper, we want to show a possible relation between anti‐TIF1‐γ and triple‐negative breast carcinoma.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsInflammatory Myopathies and Dermatomyositis · Muscle Physiology and Disorders · Cutaneous lymphoproliferative disorders research